| JNJJOHNSON & JOHNSON | 3,052,076 | $746.0M |
| RVMDREVOLUTION MEDICINES, INC. | 5,013,140 | $487.5M |
| LLYELI LILLY & Co | 460,948 | $424.0M |
| PTGXProtagonist Therapeutics, Inc | 2,828,346 | $298.1M |
| MRKMerck & Co., Inc. | 2,142,160 | $257.7M |
| DGXQuest Diagnostics Incorporated | 1,187,488 | $232.7M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 487,766 | $161.4M |
| ABBVAbbVie Inc. | 692,354 | $150.6M |
| SRRKScholar Rock Holding Corp | 3,000,940 | $147.5M |
| AMGNAMGEN INC | 411,604 | $144.8M |
| GILDGILEAD SCIENCES, INC. | 1,001,282 | $139.5M |
| DVADaVita Inc. | 905,958 | $139.2M |
| BMYBRISTOL MYERS SQUIBB CO | 2,241,276 | $135.9M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 1,517,782 | $132.0M |
| CYTKCYTOKINETICS INC | 2,000,856 | $131.9M |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 251,798 | $131.8M |
| PRAXPraxis Precision Medicines, Inc. | 400,026 | $128.9M |
| NUVLNuvalent, Inc. | 1,220,918 | $125.1M |
| IRONDisc Medicine, Inc. | 1,916,562 | $122.5M |
| GMOptec International, Inc. | 1,620,942 | $120.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 269,908 | $120.5M |
| COGTCogent Biosciences, Inc. | 3,019,114 | $116.2M |
| PFEPFIZER INC | 4,067,684 | $114.2M |
| INCYIncyte Corp. | 1,211,434 | $114.0M |
| CAHCardinal Health Inc. | 528,652 | $111.7M |
| MIRMMirum Pharmaceuticals, Inc. | 1,135,788 | $104.9M |
| REGNREGENERON PHARMACEUTICALS, INC. | 135,502 | $104.7M |
| PTCTPTC THERAPEUTICS, INC. | 1,489,976 | $101.5M |
| PMPhilip Morris International Inc | 609,804 | $100.8M |
| IMVTImmunovant, Inc. | 3,951,738 | $98.2M |
| ROIVRoivant Sciences Ltd. | 3,500,034 | $97.0M |
| ERASErasca, Inc. | 5,663,076 | $91.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 319,060 | $86.3M |
| VERAVera Therapeutics, Inc. | 2,002,074 | $80.5M |
| PVLAPALVELLA THERAPEUTICS, INC. | 635,034 | $79.2M |
| APLSApellis Pharmaceuticals, Inc. | 1,952,350 | $78.5M |
| KRYSKrystal Biotech, Inc. | 301,232 | $77.8M |
| SLNOSOLENO THERAPEUTICS INC | 2,224,208 | $74.5M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 866,914 | $72.8M |
| TEVATeva Pharmaceutical Industries Limited | 2,327,726 | $70.1M |
| IMNMImmunome Inc. | 3,150,796 | $68.9M |
| CNTACentessa Pharmaceuticals plc | 1,718,210 | $68.2M |
| CGONCG Oncology, Inc. | 985,782 | $66.7M |
| MANEVeradermics Incorporated | 1,001,292 | $63.2M |
| KALVKalVista Pharmaceuticals, Inc. | 3,019,840 | $60.8M |
| NKTRNEKTAR THERAPEUTICS | 830,670 | $59.8M |
| ABTABBOTT LABORATORIES | 572,216 | $58.7M |
| SNDXSyndax Pharmaceuticals Inc | 2,501,520 | $58.4M |
| ORKAOruka Therapeutics, Inc. | 1,149,764 | $56.4M |
| AXSMAxsome Therapeutics, Inc. | 324,442 | $54.8M |
| MBXMBX Biosciences, Inc. | 1,800,126 | $53.7M |
| INBXInhibrx Biosciences, Inc. | 768,866 | $51.7M |
| ABVXAbivax SA | 451,784 | $50.3M |
| SHCSotera Health Company | 3,461,614 | $49.6M |
| INSMINSMED Inc | 296,906 | $48.6M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 1,504,616 | $48.2M |
| TGTXTG THERAPEUTICS, INC. | 1,431,000 | $47.5M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 897,992 | $46.4M |
| SVRASavara Inc | 8,490,238 | $46.4M |
| BBIOBridgeBio Pharma, Inc. | 602,024 | $44.7M |
| OLMAOlema Pharmaceuticals, Inc. | 2,964,060 | $44.2M |
| APGEApogee Therapeutics, Inc. | 522,240 | $44.0M |
| ICUIICU Medical Inc. | 328,610 | $42.4M |
| BIIBBIOGEN INC. | 218,064 | $40.0M |
| ALKSAlkermes plc. | 1,117,134 | $39.5M |
| MAZEMaze Therapeutics, Inc. | 1,300,458 | $38.8M |
| ANABANAPTYSBIO, INC | 688,512 | $38.2M |
| MCKMcKesson Corporation | 43,370 | $37.5M |
| KYMRKymera Therapeutics, Inc. | 407,170 | $33.9M |
| PBHPrestige Consumer Healthcare Inc. | 547,886 | $32.5M |
| PCVXVaxcyte, Inc. | 549,480 | $31.9M |
| CLDXCelldex Therapeutics, Inc. | 1,000,254 | $31.7M |
| ORICOric Pharmaceuticals, Inc. | 2,495,030 | $31.6M |
| VTRSViatris Inc | 2,335,896 | $31.6M |
| HLFHerbalife Ltd. | 2,058,968 | $30.3M |
| ACADACADIA PHARMACEUTICALS INC | 1,352,802 | $30.1M |
| NRIXNurix Therapeutics, Inc. | 1,850,888 | $28.7M |
| DFTXDefinium Therapeutics Inc. | 1,505,584 | $28.5M |
| ACLXArcellx, Inc. | 247,500 | $28.4M |
| OCULOCULAR THERAPEUTIX, INC | 3,335,218 | $28.2M |
| VRDNViridian Therapeutics, Inc.\DE | 1,401,858 | $27.4M |
| SYRESpyre Therapeutics, Inc. | 531,784 | $26.8M |
| ANNXAnnexon, Inc. | 4,674,274 | $25.9M |
| CAICaris Life Sciences Inc. | 1,446,326 | $25.9M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 400,368 | $25.1M |
| TRVITrevi Therapeutics, Inc. | 2,001,564 | $23.9M |
| ELVNEnliven Therapeutics, Inc. | 603,346 | $23.7M |
| AMLXAmylyx Pharmaceuticals, Inc. | 1,691,600 | $23.5M |
| ZBIOZenas BioPharma, Inc. | 1,181,050 | $23.1M |
| TYRATyra Biosciences, Inc. | 602,080 | $23.1M |
| STROSUTRO BIOPHARMA, INC. | 914,882 | $22.8M |
| MRNAModerna, Inc. | 422,946 | $21.5M |
| JANXJanux Therapeutics, Inc. | 1,476,064 | $20.5M |
| DSGNDesign Therapeutics, Inc. | 1,923,002 | $20.5M |
| VKTXViking Therapeutics, Inc. | 605,502 | $19.7M |
| IMTXImmatics N.V. | 2,001,194 | $19.7M |
| IMCRImmunocore Holdings plc | 633,524 | $19.1M |
| CTMXCytomX Therapeutics, Inc. | 4,001,650 | $18.8M |
| GPCRStructure Therapeutics Inc. | 381,616 | $18.4M |
| ACHCAcadia Healthcare Company Inc. | 781,660 | $18.3M |
| ABUSArbutus Biopharma Corp | 4,020,344 | $18.1M |
| URGNUroGen Pharma Ltd. | 1,001,452 | $18.0M |
| TVTXTravere Therapeutics, Inc. | 605,332 | $18.0M |
| VCELVericel Corp | 543,504 | $17.5M |
| XENEXenon Pharmaceuticals Inc. | 300,604 | $17.5M |
| FBRXForte Biosciences, Inc. | 663,974 | $17.2M |
| ALLOAllogene Therapeutics, Inc. | 7,002,156 | $17.1M |
| UPBUpstream Bio, Inc. | 1,662,962 | $15.0M |
| QGENQIAGEN N.V. | 370,036 | $14.8M |
| KYTXKyverna Therapeutics, Inc. | 1,690,650 | $14.6M |
| EWTXEdgewise Therapeutics, Inc. | 448,580 | $14.1M |
| TARSTarsus Pharmaceuticals, Inc. | 200,886 | $14.1M |
| DNLIDenali Therapeutics Inc. | 728,164 | $14.0M |
| ELVElevance Health Inc. | 47,306 | $13.8M |
| IPSCCentury Therapeutics, Inc. | 6,086,956 | $13.8M |
| AUPHAurinia Pharmaceuticals Inc. | 912,518 | $13.5M |
| RLAYRelay Therapeutics, Inc. | 1,358,684 | $13.5M |
| IDYAIDEAYA Biosciences, Inc. | 403,334 | $13.4M |
| SRZNSurrozen Inc. | 455,696 | $13.3M |
| ZBHZimmer Biomet Holdings Inc. | 146,572 | $13.3M |
| LRMRLarimar Therapeutics, Inc. | 2,801,700 | $12.6M |
| IRDOpus Genetics, Inc. | 2,708,060 | $12.3M |
| GMEDGlobus Medical Inc. | 136,816 | $11.8M |
| SNSESensei Biotherapeutics, Inc. | 361,010 | $11.4M |
| IQVIQVIA Holdings Inc. | 66,494 | $11.3M |
| ACRSAclaris Therapeutics, Inc. | 2,971,246 | $11.1M |
| PGENPRECIGEN, INC. | 2,802,824 | $10.8M |
| OCSOculis Holding AG | 402,400 | $10.7M |
| BCAXBicara Therapeutics Inc. | 465,380 | $9.3M |
| ARQTArcutis Biotherapeutics, Inc. | 390,066 | $9.2M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 2,583,968 | $9.1M |
| ETONEton Pharmaceuticals, Inc. | 341,398 | $8.4M |
| CAPRCAPRICOR THERAPEUTICS, INC. | 275,310 | $8.4M |
| XFORX4 Pharmaceuticals, Inc | 2,002,190 | $8.3M |
| NUVBNuvation Bio Inc. | 1,920,828 | $8.2M |
| PHATPhathom Pharmaceuticals, Inc. | 738,104 | $8.2M |
| SMMTSummit Therapeutics Inc. | 429,014 | $8.1M |
| DAWNDay One Biopharmaceuticals, Inc. | 378,114 | $8.1M |
| SANASana Biotechnology, Inc. | 2,635,864 | $7.6M |
| LQDALiquidia Corp | 200,320 | $7.6M |
| LEGNLegend Biotech Corp | 411,740 | $7.4M |
| RAREUltragenyx Pharmaceutical Inc. | 343,610 | $7.2M |
| SLDBSolid Biosciences Inc. | 990,152 | $7.1M |
| AVBPArriVent BioPharma, Inc. | 295,278 | $6.8M |
| CABACabaletta Bio, Inc. | 2,500,484 | $6.7M |
| DRUGBRIGHT MINDS BIOSCIENCES INC. | 91,336 | $6.7M |
| LNTHLantheus Holdings, Inc. | 84,764 | $6.4M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 881,102 | $6.4M |
| RIOTRiot Platforms, Inc. | 501,722 | $6.2M |
| TECXTectonic Therapeutic, Inc. | 200,000 | $6.2M |
| RLMDRELMADA THERAPEUTICS, INC. | 842,104 | $5.9M |
| REPLReplimune Group, Inc. | 761,976 | $5.8M |
| TRDAEntrada Therapeutics, Inc. | 431,954 | $5.5M |
| DYNDyne Therapeutics, Inc. | 298,776 | $5.4M |
| MGTXMeiraGTx Holdings plc | 600,646 | $5.2M |
| NTLAIntellia Therapeutics, Inc. | 401,996 | $5.2M |
| WVEWave Life Sciences Ltd. | 701,062 | $5.1M |
| BHVNBiohaven Ltd. | 600,778 | $5.1M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 148,846 | $5.0M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 200,956 | $5.0M |
| TSHATaysha Gene Therapies, Inc. | 1,027,656 | $4.6M |
| RCKTRocket Pharmaceuticals Inc. | 1,282,444 | $4.6M |
| ATAIAtai Beckley N.V. | 1,200,000 | $4.2M |
| PLRXPLIANT THERAPEUTICS, INC. | 3,333,660 | $4.2M |
| UTHRUNITED THERAPEUTICS Corp | 6,954 | $4.1M |
| ZTSZoetis Inc. | 34,382 | $4.1M |
| RZLTRezolute, Inc. | 1,223,594 | $3.7M |
| FDMT4D Molecular Therapeutics, Inc. | 400,002 | $3.7M |
| AKTSAktis Oncology Inc. | 200,000 | $3.6M |
| MNKDMANNKIND CORP | 1,438,268 | $3.5M |
| NGNENeurogene Inc. | 167,670 | $3.4M |
| STOKStoke Therapeutics, Inc. | 100,240 | $3.3M |
| CBIOCRESCENT BIOPHARMA, INC. | 148,000 | $2.7M |
| RIGLRIGEL PHARMACEUTICALS INC | 100,000 | $2.7M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 15,426 | $2.7M |
| GEHCGE HealthCare Technologies Inc. | 35,544 | $2.5M |
| GLUEMonte Rosa Therapeutics, Inc. | 148,992 | $2.5M |
| CRNXCrinetics Pharmaceuticals, Inc. | 65,634 | $2.4M |
| KURAKura Oncology, Inc. | 291,408 | $2.4M |
| WHWKWhitehawk Therapeutics, Inc. | 562,994 | $1.9M |
| CMPSCOMPASS Pathways plc | 350,878 | $1.9M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 207,414 | $1.9M |
| LENZLENZ Therapeutics, Inc. | 200,000 | $1.8M |
| PROKPROKIDNEY CORP. | 1,000,000 | $1.8M |
| FHTXFoghorn Therapeutics Inc. | 360,666 | $1.7M |
| IDXXIDEXX LABORATORIES INC /DE | 2,910 | $1.6M |
| CADLCandel Therapeutics, Inc. | 313,400 | $1.5M |
| RPRXRoyalty Pharma plc | 31,510 | $1.5M |
| VYGRVoyager Therapeutics, Inc. | 387,968 | $1.5M |
| WSTWest Pharmaceutical Services Inc. | 5,612 | $1.4M |
| CNTXContext Therapeutics Inc. | 500,176 | $1.3M |
| ZNTLZentalis Pharmaceuticals, Inc. | 532,064 | $1.2M |
| KLRSKalaris Therapeutics, Inc. | 200,000 | $1.2M |
| NBIXNEUROCRINE BIOSCIENCES INC | 7,780 | $1.0M |
| TBPHTheravance Biopharma, Inc. | 60,244 | $978K |
| CORCencora Inc. | 2,808 | $882K |
| RNAAtrium Therapeutics Inc. | 57,690 | $771K |
| NKTXNkarta, Inc. | 336,220 | $709K |
| ESPREsperion Therapeutics, Inc. | 254,056 | $696K |
| NXTCNextCure, Inc. | 54,996 | $587K |
| FATEFATE THERAPEUTICS INC | 477,300 | $573K |
| AARDAardvark Therapeutics, Inc. | 144,858 | $546K |
| FULCFulcrum Therapeutics, Inc. | 61,586 | $472K |